miRNA-137在骨肉瘤中的作用及机制研究Role of miRNA-137 in osteosarcoma and its mechanism of action
周强;李颖;张恩军;刘琨;
摘要(Abstract):
[目的]通过转染miRNA-137至人骨肉瘤细胞MG-63,观察细胞内TWIST蛋白含量变化及其对细胞增殖活性的影响以探讨miRNA-137在骨肉瘤中的作用及机制。[方法]Target Scan预测miRNA-137与TWIST结合靶位;PCR扩增TWIST基因3’UTR区并克隆至荧光素酶报告基因表达载体;化学法合成miRNA-137 mimics,miRNA-137 inhibitor及NC序列,与荧光素酶报告基因表达载体共转染293细胞,48 h后检测荧光素酶活性;转染miRNA-137至MG-63细胞,转染后48 h,Real Time-PCR检测转染后细胞内miRNA-137含量,Western-blot检测细胞中TWIST蛋白含量变化;转染后0~72 h,CCK-8检测肿瘤细胞增殖活性。[结果]证实了miRNA-137与其靶基因TWIST的结合位点;miRNA-137 mimics转染MG-63细胞,可明显抑制细胞内TWIST蛋白表达,与对照组比较,差异有统计学意义(P<0.05),而miRNA-137 inhibitor转染细胞后可明显增强胞内TWIST蛋白的表达,与对照组比较差异有统计学意义(P<0.05));miRNA-137 mimics可明显抑制MG-63细胞对数期增殖活性,而miRNA-137 inhibitor则使细胞增殖活性进一步增强,相同时间点与对照相比较,均有差异(P<0.05)。[结论]miRNA-137可以通过抑制其靶基因TWIST表达来抑制MG-63细胞增殖活性。
关键词(KeyWords): miRNA-137;MG-63;荧光素酶;TWIST;细胞活性
基金项目(Foundation):
作者(Author): 周强;李颖;张恩军;刘琨;
Email:
DOI:
参考文献(References):
- [1]Grzegrzolka J,Biala M,Wojtyra P,et al.Expression of EMT markers SLUG and TWIST in breast cancer[J].Anticancer Res,2015,35(7):3961-3968.
- [2]Ji H,Lu HW,Li YM,et al.Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15.Mol Med Rep.2015 May 27.[Epub ahead of print]
- [3]Zhang H,Gong J,Kong D,et al.Anti-proliferation effects of Twist gene silencing in gastric cancer SGC7901 cells[J].World J Gastroenterol,2015;21(10):2926-2936.
- [4]Kim K,Park EY,Yoon MS,et al.The role of TWIST in ovarian epithelial cancers[J].Korean J Pathol,2014,48(4):283-291.
- [5]Han Z,Liu L,Liu Y,et al.Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer[J].Int J Clin Exp Pathol,2014,7(8):4774-4781.
- [6]Ansieau S,Bastid J,Doreau A,et al.Induction of emt by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence[J].Cancer cell,2008,14(1):79-89.
- [7]Fu J,Qin L,He T,Qin J,et al.The twist/mi2/nurd protein complex and its essential role in cancer metastasis[J].Cell research,2011,21:275-289.
- [8]Kloosterman WP,Plasterk RH.The diverse functions of micrornas in animal development and disease[J].Developmental cell,2006,11:441-450.
- [9]Sun K,Lai EC.Adult-specific functions of animal micrornas.Nature reviews[J].Genetics,2013,14:535-548.
- [10]Ambros V.The functions of animal micrornas[J].Nature,2004,431:350-355.
- [11]Markou A,Tsaroucga EG,KaklamanisL,et al.Prognosticvalue od maturemicro RNA 21 and microRNA 205 over expressioninnon small cell lung cancer by quantitativereal time RT PCR[J].Clin Chem,2008,54(10):1696-1704.
- [12]Takamizawa J,Konishi H,Yanagisawa K,et al.Reduced expres sion of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival[J].Cancer Res,2004,64(11):3753-3756.
- [13]Yanaihara N,Caplen N,Bowman E,et al.Unique microRNA mo lecular profiles in lung cancer diagnosis and prognosis[J].Cancer Cell,2006(3):189-198.
- [14]Budhu A,Jia HL,Forgues M,et al.Identification of metastasis related microRNAs in hepatocellular carcinoma[J].Hepatology,2008,47(3):897-907.
- [15]Ding M,Hu J,Ni J,et al.Demethylation of microRNA-142 induced by demethylation agents plays a suppressive role in osteosarcoma cells[J].Oncol Lett,2015,9(5):2261-2267.
- [16]Zhu SW,Li JP,Ma XL,et al.miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor[J].Asian Pac JCancer Prev,2015,16(11):4509-4513.
- [17]Shi ZC,Chu XR,Wu YG,et al.MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.Tumour Biol.2015Jun 3.[Epub ahead of print]
- [18]Hou CH,Lin FL,Hou SM,et al.Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway[J].Mol Cancer,2014,13:236.
- [19]Zhou Y,Huang Z,Wu S,et al.miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST[J].J Exp Clin Cancer,2014,33(1):12.
- [20]Chen J,Xia J,Yu YL,et al.HDAC5 promotes osteosarcoma progression by upregulation of Twist 1 expression[J].Tumour Biol,2014,35(2):1383-1387.